Metabolomic profiling reveals altered amino acid and neurotransmitter levels in Parkinson's disease, suggesting metabolic dysregulation.
Serum metabolomic profiling in Parkinson’s disease (PD) remains underexplored. This study characterized alterations in serum amino acid and neurotransmitter levels in PD using targeted metabolomics and identify associated dysregulated metabolic...
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: